Post Approval Registry of Corox OTW, Endocardial, Left Ventricular Steroid Lead, Bipolar

NCT00810264 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2499

Last updated 2019-11-29

Study results available
· View outcomes & findings →

Summary

The objective of this study is to confirm the long-term safety and reliability of the Corox OTW BP left ventricular (LV) pacing lead. As a condition of approval, the FDA required that a registry documenting the post approval clinical experience of these leads be designed and implemented.

Conditions

  • Congestive Heart Failure

Interventions

DEVICE

CRT Therapy - LV Lead Registry

Collecting long-term safety and efficacy data on a market-released left ventricular lead.

Sponsors & Collaborators

  • Biotronik, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2018-11-02
Completion
2018-11-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00810264 on ClinicalTrials.gov